About Us
Founded on December 21, 2023, in Delaware and operated from California, we embarked on our mission with a clear vision and a relentless drive to make a difference in the world of cardiology. Our roots trace back to the visionary minds at AmberTAG Inc., our promoter, who saw the potential in harnessing AI to revolutionize heart failure management.
Led by Amar Kumar Ray, our founder and dedicated CEO, HAIF Inc., represents a synergy of pioneering spirits and expertise.
Bharat Vijay (Co-founder), with his rich background in successful tech ventures, and Amar, with his multifaceted experience in healthcare delivery, form the core of our leadership.
Dr. Abhijit Ray, Interventional Cardiologist and Heart Failure Specialist is trained at Royal College of Physicians of Edinburgh and King’s College London, UK ; Fellow of Harvard Medical School, USA and FRCP (Lon.). Dr. Ray is the livewire of the Clinical Research and SME communications.
Our Founders’ rich experiences and formidable successes, marked by impactful exits in both cardiac and non-cardiac areas, sets a solid foundation for HAIF’s ambitious vision
Our journey began with a simple yet profound goal: to predict and prevent heart failure using cutting-edge AI technology. This led to the creation of our flagship product, the Heart Failure Predictor (HFP), which, within just three months of inception, garnered significant acclaim, securing 10,000 subscriptions.
At the heart of HAIF Inc. lies a steadfast commitment to Quality, Security, Privacy, though process excellence. Guided by the stringent standards set by our parent company, AmberTAG, we’ve woven a culture of compliance and discipline, adhering to ISO guidelines, and working towards HIPAA and CCPA compliances.
Our process-oriented approach, coupled with a layered strategy for execution, ensures that every member of HAIF Inc. contributes to our collective success, all while maintaining the highest standards of privacy and security.
Our founders, seasoned in both cardiac and non-cardiac ventures, have set a clear directive: to not only lead in innovation but also in post-sales support and service. Following the ITIL framework, we’re committed to providing unparalleled support to our clients, ensuring that every interaction with HAIF Inc. is positive and impactful.
As we move forward, HAIF Inc. remains dedicated to its mission of transforming the landscape of heart failure management. Our journey is fueled by innovation, driven by excellence, and inspired by the countless lives we aspire to touch.
An innovative, patented in the US, state-of-the-art system created to evaluate and forecast the likelihood, as well as identify the occurrence, of heart failure with unparalleled precisions.
Elevate patient care with (Heart Failure Predictor) HFP, transforming heart health outcomes
Gain a competitive edge and global reach with HFP integration
Offer comprehensive, data-driven solutions, empowered by HFP technology.
HAIF benefits different types of Healthcare institutions. HAIF transforms patient care in institutes, gives ECG device manufacturers a competitive edge and global reach, while empowering software providers to offer comprehensive, data-driven solutions.
This juncture holds the key for both manufacturers and governments. A shrinking market is a looming threat to income and growth. The Heart Failure Predictor offers not just a solution but a promise—a promise that the entry of numerous users could elevate the total income from this field over time. It’s a turning point. Manufacturers and governments need to pivot from concerns to active participation, ensuring that this innovation is not just accepted but embraced. By doing so, we unlock a future where both sectors flourish, creating a win-win scenario that safeguards income and paves the way for a healthier tomorrow.
In the journey to a healthier tomorrow, it appears that the Heart Failure Predictor may elevate USA’s healthcare global ranking by some notches.
Meet the Experts Behind the Innovation in Heart Health.
Multi-domain success in Delivery of healthcare, finance, training. Masterminded entire team to success in cardiology-electrophysiology initiative for catheter ablation including FDA approval and successful team exit
MD (Royal Coll.), DM, FRCP, Patent holder SME
A Harvard fellow & one of the youngest Cardiologists. IP Holder in many medical areas including cardiology, renal, dengue treatment and more.
Digital Marketing and Sales Wizard with success in healthcare, real estate, e-commerce and more
Built scale at Yahoo!, Amazon, 3 successful company Exits – uGenie (2009), Boltell (2020), Neutrace (2023) One of the earliest AI engineers in the industry